If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020
Open Access

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment: Clinical and Translational Oncology

Bonaventura, A., Grossi, F., Carbone, F., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Rossi, G., Biello, F., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., 2020, In : Clin. Transl. Oncol.. 22, 9, p. 1603-1610 8 p.

Research output: Contribution to journalArticle

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment

Bonaventura, A., Grossi, F., Carbone, F., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Rossi, G., Biello, F., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., Jan 1 2020, (Accepted/In press) In : Clinical and Translational Oncology.

Research output: Contribution to journalArticle

2019

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer: Clinical and Experimental Metastasis

Carbone, F., Grossi, F., Bonaventura, A., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Biello, F., Rossi, G., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., 2019, In : Clin. Exp. Metastasis. 36, 5, p. 449-456 8 p.

Research output: Contribution to journalArticle

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer

Carbone, F., Grossi, F., Bonaventura, A., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Biello, F., Rossi, G., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., Oct 15 2019, In : Clinical and Experimental Metastasis. 36, 5, p. 449-456 8 p.

Research output: Contribution to journalArticle

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

Genova, C., Boccardo, S., Mora, M., Rijavec, E., Biello, F., Rossi, G., Tagliamento, M., Dal Bello, M. G., Coco, S., Alama, A., Vanni, I., Barletta, G., Bianchi, R., Maggioni, C., Bruzzi, P. & Grossi, F., Oct 1 2019, In : Journal of Clinical Medicine. 8, 10

Research output: Contribution to journalArticle

Integrated somatic and germline whole-exome sequencing analysis inwomen with lung cancer after a previous breast cancer

Coco, S., Bonfiglio, S., Cittaro, D., Vanni, I., Mora, M., Genova, C., Bello, M. G. D., Boccardo, S., Alama, A., Rijavec, E., Sini, C., Rossella, V., Barletta, G., Biello, F., Truini, A., Bruzzo, C., Gallo, M., Lazarevic, D., Ballestrero, A. & Grossi, F., Apr 1 2019, In : Cancers. 11, 4, 441.

Research output: Contribution to journalArticle

Open Access

Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer

Coco, S., Bonfiglio, S., Cittaro, D., Vanni, I., Mora, M., Genova, C., Dal Bello, M. G., Boccardo, S., Alama, A., Rijavec, E., Sini, C., Rossella, V., Barletta, G., Biello, F., Truini, A., Bruzzo, C., Gallo, M., Lazarevic, D., Ballestrero, A. & Grossi, F., Mar 28 2019, In : Cancers. 11, 4

Research output: Contribution to journalArticle

Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds

Tagliamento, M., Genova, C., Rossi, G., Coco, S., Rijavec, E., Dal Bello, M. G., Boccardo, S., Grossi, F. & Alama, A., 2019, In : Expert Opinion on Investigational Drugs. 28, 6, p. 513-523 11 p.

Research output: Contribution to journalArticle

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab

Alama, A., Coco, S., Genova, C., Rossi, G., Fontana, V., Tagliamento, M., Giovanna Dal Bello, M., Rosa, A., Boccardo, S., Rijavec, E., Biello, F., Longo, L., Cavalieri, Z., Bruzzo, C. & Grossi, F., Jul 10 2019, In : Journal of Clinical Medicine. 8, 7, 1011.

Research output: Contribution to journalArticle

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study

Bonaventura, A., Grossi, F., Carbone, F., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Rossi, G., Biello, F., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., Jan 1 2019, In : Cancer Immunology, Immunotherapy. 68, 8, p. 1351-1358

Research output: Contribution to journalArticle

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study

Bonaventura, A., Grossi, F., Carbone, F., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Rossi, G., Biello, F., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., 2019, In : Cancer Immunology and Immunotherapy. 68, 8, p. 1351-1358 8 p.

Research output: Contribution to journalArticle

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

Dal Bello, M. G., Filiberti, R. A., Alama, A., Orengo, A. M., Mussap, M., Coco, S., Vanni, I., Boccardo, S., Rijavec, E., Genova, C., Biello, F., Barletta, G., Rossi, G., Tagliamento, M., Maggioni, C. & Grossi, F., 2019, In : Journal of Translational Medicine. 17, 1, 74.

Research output: Contribution to journalArticle

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

Dal Bello, M. G., Filiberti, R. A., Alama, A., Orengo, A. M., Mussap, M., Coco, S., Vanni, I., Boccardo, S., Rijavec, E., Genova, C., Biello, F., Barletta, G., Rossi, G., Tagliamento, M., Maggioni, C. & Grossi, F., Mar 8 2019, In : Journal of Translational Medicine. 17, 1, 74.

Research output: Contribution to journalArticle

Open Access
2018

Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

Tagliamento, M., Genova, C., Rijavec, E., Rossi, G., Biello, F., Dal Bello, M. G., Alama, A., Coco, S., Boccardo, S. & Grossi, F., 2018, In : Expert Opinion on Pharmacotherapy. 19, 18, p. 2055-2062 8 p.

Research output: Contribution to journalArticle

Lung cancer predisposition in women with previous breast cancer identified by whole exome sequencing

Grossi, F., Genova, C., Cittaro, D., Bonfiglio, S., Boccardo, S., Vanni, I., Mora, M., Dal Bello, M. G., Biello, F., Rijavec, E., Sini, C., Rossi, G., Tagliamento, M., Alama, A., Burrafato, G., Barletta, G., Ballestrero, A. & Coco, S., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii674

Research output: Contribution to journalArticle

Open Access

The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer

Rossi, G., Alama, A., Genova, C., Rijavec, E., Tagliamento, M., Biello, F., Coco, S., Dal Bello, M. G., Boccardo, S. & Grossi, F., 2018, In : Expert Opinion on Pharmacotherapy. 19, 17, p. 1969-1976 8 p.

Research output: Contribution to journalArticle

The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer

Rossi, G., Alama, A., Genova, C., Rijavec, E., Tagliamento, M., Biello, F., Coco, S., Dal Bello, M. G., Boccardo, S. & Grossi, F., 2018, In : Expert Opinion on Pharmacotherapy. 19, 17, p. 1969-1976

Research output: Contribution to journalArticle

2017

Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy

Coco, S., Alama, A., Vanni, I., Fontana, V., Genova, C., Bello, M. G. D., Truini, A., Rijavec, E., Biello, F., Sini, C., Burrafato, G., Maggioni, C., Barletta, G. & Grossi, F., May 11 2017, In : International Journal of Molecular Sciences. 18, 5, 1035.

Research output: Contribution to journalArticle

Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer: 18F-FDG PET/CT study

Morbelli, S., Alama, A., Ferrarazzo, G., Coco, S., Genova, C., Rijavec, E., Bongioanni, F., Biello, F., Dal Bello, M. G., Barletta, G., Massollo, M., Vanni, I., Piva, R., Nieri, A., Bauckneht, M., Sambuceti, G. & Grossi, F., Nov 1 2017, In : Journal of Nuclear Medicine. 58, 11, p. 1764-1769 6 p.

Research output: Contribution to journalArticle

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma

Truini, A., Coco, S., Nadal, E., Genova, C., Mora, M., Dal Bello, M. G., Vanni, I., Alama, A., Rijavec, E., Biello, F., Barletta, G., Merlo, D. F., Valentino, A., Ferro, P., Ravetti, G. L., Stigliani, S., Vigani, A., Fedeli, F., Beer, D. G., Roncella, S. & 1 others, Grossi, F., Sep 15 2017, In : Oncotarget. 8, 40, p. 68627-68640 14 p.

Research output: Contribution to journalArticle

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma

Truini, A., Coco, S., Nadal, E., Genova, C., Mora, M., Dal Bello, M. G., Vanni, I., Alama, A., Rijavec, E., Biello, F., Barletta, G., Merlo, D. F., Valentino, A., Ferro, P., Ravetti, G. L., Stigliani, S., Vigani, A., Fedeli, F., Beer, D. G., Roncella, S. & 1 others, Grossi, F., Sep 15 2017, In : Oncotarget. 8, 40, p. 68627-68640 14 p.

Research output: Contribution to journalArticle

2016

Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy

Biello, F., Burrafato, G., Rijavec, E., Genova, C., Barletta, G., Truini, A., Coco, S., Bello, M. G. D., Alama, A., Boccardo, F. & Grossi, F., 2016, In : Anti-Cancer Agents in Medicinal Chemistry. 16, 9, p. 1142-54 13 p.

Research output: Contribution to journalArticle

Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples

Bonfiglio, S., Vanni, I., Rossella, V., Truini, A., Lazarevic, D., Dal Bello, M. G., Alama, A., Mora, M., Rijavec, E., Genova, C., Cittaro, D., Grossi, F. & Coco, S., Aug 30 2016, In : BMC Cancer. 16, 1, 692.

Research output: Contribution to journalArticle

Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples

Bonfiglio, S., Vanni, I., Rossella, V., Truini, A., Lazarevic, D., Dal Bello, M. G., Alama, A., Mora, M., Rijavec, E., Genova, C., Cittaro, D., Grossi, F. & Coco, S., Aug 30 2016, In : BMC Cancer. 16, 1, 692.

Research output: Contribution to journalArticle

Vinflunine for the treatment of non-small cell lung cancer

Genova, C., Alama, A., Coco, S., Rijavec, E., Dal Bello, M. G., Vanni, I., Biello, F., Barletta, G., Rossi, G. & Grossi, F., Dec 1 2016, In : Expert Opinion on Investigational Drugs. 25, 12, p. 1447-1455 9 p.

Research output: Contribution to journalArticle

Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report

Vanni, I., Coco, S., Bonfiglio, S., Cittaro, D., Genova, C., Biello, F., Mora, M., Rossella, V., Dal Bello, M. G., Truini, A., Banelli, B., Lazarevic, D., Alama, A., Rijavec, E., Barletta, G. & Grossi, F., 2016, In : Medicine (United States). 95, 48, p. e5447

Research output: Contribution to journalArticle

Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report

Vanni, I., Coco, S., Bonfiglio, S., Cittaro, D., Genova, C., Biello, F., Mora, M., Rossella, V., Dal Bello, M. G., Truini, A., Banelli, B., Lazarevic, D., Alama, A., Rijavec, E., Barletta, G. & Grossi, F., 2016, In : Medicine (United States). 95, 48, p. e5447 -

Research output: Contribution to journalArticle

2015

Afatinib for the treatment of non-small cell lung cancer

Biello, F., Maggioni, C., Rijavec, E., Genova, C., Barletta, G., Gualco, E., Truini, A., Coco, S., Dal Bello, M. G., Vanni, I., Alama, A., Boccardo, F. & Grossi, F., Nov 2 2015, In : Expert Opinion on Orphan Drugs. 3, 11, p. 1357-1364 8 p.

Research output: Contribution to journalArticle

Belagenpumatucel-L for the treatment of non-small cell lung cancer

Rijavec, E., Biello, F., Genova, C., Barletta, G., Maggioni, C., Dal Bello, M. G., Coco, S., Truini, A., Vanni, I., Alama, A., Beltramini, S., Grassi, M. A., Boccardo, F. & Grossi, F., Sep 2 2015, In : Expert Opinion on Biological Therapy. 15, 9, p. 1371-1379 9 p.

Research output: Contribution to journalArticle

CD133-Positive Cells from Non-Small Cell Lung Cancer Show Distinct Sensitivity to Cisplatin and Afatinib

Alama, A., Gangemi, R., Ferrini, S., Barisione, G., Orengo, A. M., Truini, M., Bello, M. G. D. & Grossi, F., Jun 1 2015, In : Archivum Immunologiae et Therapiae Experimentalis. 63, 3, p. 207-214 8 p.

Research output: Contribution to journalArticle

Conjugation of Hydroxytyrosol with Other Natural Phenolic Fragments: From Waste to Antioxidants and Antitumour Compounds

Tassano, E., Alama, A., Basso, A., Dondo, G., Galatini, A., Riva, R. & Banfi, L., Oct 1 2015, In : European Journal of Organic Chemistry. 2015, 30, p. 6710-6726 17 p.

Research output: Contribution to journalArticle

Expression of ribonucleotide reductase subunit-2 and thymidylate synthase correlates with poor prognosis in patients with resected stages I-III non-small cell lung cancer

Grossi, F., Dal Bello, M. G., Salvi, S., Puzone, R., Pfeffer, U., Fontana, V., Alama, A., Rijavec, E., Barletta, G., Genova, C., Sini, C., Ratto, G. B., Taviani, M., Truini, M. & Merlo, D. F., 2015, In : Disease Markers. 2015, 302649.

Research output: Contribution to journalArticle

Isolation and characterization of circulating tumor cells in squamous cell carcinoma of the lung using a non-EpCAM-based capture method

Bozzetti, C., Quaini, F., Squadrilli, A., Tiseo, M., Frati, C., Lagrasta, C., Azzoni, C., Bottarelli, L., Galetti, M., Alama, A., Belletti, S., Gatti, R., Passaro, A., Gradilone, A., Cavazzoni, A., Alfieri, R., Petronini, P. G., Bonelli, M., Falco, A., Carubbi, C. & 5 others, Pedrazzi, G., Nizzoli, R., Naldi, N., Pinto, C. & Ardizzoni, A., Nov 1 2015, In : PLoS One. 10, 11, e0142891.

Research output: Contribution to journalArticle

Next generation sequencing in non-small cell lung cancer: New avenues toward the personalized medicine

Coco, S., Truini, A., Vanni, I., Dal Bello, M. G., Alama, A., Rijavec, E., Genova, C., Barletta, G., Sini, C., Burrafato, G., Biello, F., Boccardo, F. & Grossi, F., Jan 1 2015, In : Current Drug Targets. 16, 1, p. 47-59 13 p.

Research output: Contribution to journalArticle

Next-generation sequencing workflow for NSCLC critical samples using a targeted sequencing approach by ion torrent PGM™ platform

Vanni, I., Coco, S., Truini, A., Rusmini, M., Dal Bello, M. G., Alama, A., Banelli, B., Mora, M., Rijavec, E., Barletta, G., Genova, C., Biello, F., Maggioni, C. & Grossi, F., Dec 3 2015, In : International Journal of Molecular Sciences. 16, 12, p. 28765-28782 18 p.

Research output: Contribution to journalArticle

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors

Dal Bello, M. G., Alama, A., Barletta, G., Coco, S., Truini, A., Vanni, I., Boccardo, S., Genova, C., Rijavec, E., Biello, F., Bottoni, G., Sambuceti, G. & Grossi, F., Dec 15 2015, In : International Journal of Cancer. 137, 12, p. 2947-2958 12 p.

Research output: Contribution to journalArticle

Uncommon EGFR Exon 19 mutations confer gefitinib resistance in advanced lung adenocarcinoma

Coco, S., Truini, A., Vanni, I., Genova, C., Rosano, C., Dal Bello, M. G., Alama, A., Venè, R., Rijavec, E., Barletta, G., Biello, F., Boccardo, F. & Grossi, F., Jun 30 2015, In : Journal of Thoracic Oncology. 10, 6, p. e50-e52

Research output: Contribution to journalArticle

2014

Afatinib for the treatment of advanced non-small-cell lung cancer

Genova, C., Rijavec, E., Barletta, G., Burrafato, G., Biello, F., Dal Bello, M. G., Coco, S., Truini, A., Alama, A., Boccardo, F. & Grossi, F., 2014, In : Expert Opinion on Pharmacotherapy. 15, 6, p. 889-903 15 p.

Research output: Contribution to journalArticle

Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition

Coco, S., Truini, A., Alama, A., Dal Bello, M. G., Venè, R., Garuti, A., Carminati, E., Rijavec, E., Genova, C., Barletta, G., Sini, C., Ballestrero, A., Boccardo, F. & Grossi, F., Oct 25 2014, In : Targeted Oncology. 10, 3, p. 393-404 12 p.

Research output: Contribution to journalArticle

Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system

Truini, A., Alama, A., Dal-Bello, M. G., Coco, S., Vanni, I., Rijavec, E., Genova, C., Barletta, G., Biello, F. & Grossi, F., 2014, In : Frontiers in Oncology. 4 AUG, Article 242.

Research output: Contribution to journalArticle

Efficacy of motesanib diphosphate in non-small-cell lung cancer

Rijavec, E., Genova, C., Barletta, G., Biello, F., Dal Bello, M. G., Coco, S., Truini, A., Vanni, I., Alama, A., Boccardo, F. & Grossi, F., 2014, In : Expert Opinion on Pharmacotherapy. 15, 12, p. 1771-1780 10 p.

Research output: Contribution to journalArticle

Ipilimumab in non-small cell lung cancer and small-cell lung cancer: New knowledge on a new therapeutic strategy

Rijavec, E., Genova, C., Barletta, G., Burrafato, G., Biello, F., Dal Bello, M. G., Coco, S., Truini, A., Alama, A., Boccardo, F. & Grossi, F., 2014, In : Expert Opinion on Biological Therapy. 14, 7, p. 1007-1017 11 p.

Research output: Contribution to journalArticle

Oral vinorelbine in the treatment of non-small-cell lung cancer

Barletta, G., Genova, C., Rijavec, E., Burrafato, G., Biello, F., Sini, C., Dal Bello, M. G., Coco, S., Truini, A., Vanni, I., Alama, A., Beltramini, S., Grassi, M. A., Boccardo, F. & Grossi, F., 2014, In : Expert Opinion on Pharmacotherapy. 15, 11, p. 1585-1599 15 p.

Research output: Contribution to journalArticle

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer

Alama, A., Truini, A., Coco, S., Genova, C. & Grossi, F., 2014, In : Drug Discovery Today. 19, 10, p. 1671-1676 6 p.

Research output: Contribution to journalArticle

Role of immunotherapy in the treatment of advanced non-small-cell lung cancer

Rijavec, E., Genova, C., Alama, A., Barletta, G., Sini, C., Pronzato, P., Coco, S., Bello, M. G. D., Savarino, G., Truini, A., Boccardo, F. & Grossi, F., Jan 1 2014, In : Future Oncology. 10, 1, p. 79-90 12 p.

Research output: Contribution to journalArticle

Role of microRNAs in malignant mesothelioma

Truini, A., Coco, S., Alama, A., Genova, C., Sini, C., Dal Bello, M. G., Barletta, G., Rijavec, E., Burrafato, G., Boccardo, F. & Grossi, F., 2014, In : Cellular and Molecular Life Sciences. 71, 15, p. 2865-2878 14 p.

Research output: Contribution to journalArticle

2013

Glutathione S-transferase P1-1 as a target for mesothelioma treatment

De Luca, A., Pellizzari Tregno, F., Sau, A., Pastore, A., Palumbo, C., Alama, A., Cicconi, R., Federici, G. & Caccuri, A. M., Feb 2013, In : Cancer Science. 104, 2, p. 223-230 8 p.

Research output: Contribution to journalArticle

Pemetrexed for the treatment of non-small cell lung cancer

Genova, C., Rijavec, E., Truini, A., Coco, S., Sini, C., Barletta, G., Dal Bello, M. G., Alama, A., Savarino, G., Pronzato, P., Boccardo, F. & Grossi, F., Aug 2013, In : Expert Opinion on Pharmacotherapy. 14, 11, p. 1545-1558 14 p.

Research output: Contribution to journalArticle